UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study

Alimentary pharmacology & therapeutics, 2005-08, Vol.22 (3), p.227-232

2005

Volltextzugriff (PDF)

F-14 Hypophosphatemia in Caucasian HBV patients treated with tenofovir is influenced by previous adefovir treatement

Digestive and liver disease, 2013-02, Vol.45, p.S35-S35

2013

Volltextzugriff (PDF)

Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen‐negative chronic hepatitis B

Alimentary pharmacology & therapeutics, 2004-08, Vol.20 (3), p.281-287

2004

Volltextzugriff (PDF)

Treatment of chronic hepatitis B

Current pharmaceutical design, 2002-01, Vol.8 (11), p.953-958

2002

Volltextzugriff (PDF)

Current pharmacotherapy for the treatment of chronic hepatitis B

Expert opinion on pharmacotherapy, 2003-10, Vol.4 (10), p.1821-1827

2003

Volltextzugriff (PDF)

[712] IS LIVER STIFFNESS MEASUREMENT DIFFERENT IN PATIENTS WITH NASH OR WITH VIRAL HEPATITIS?

Journal of hepatology, 2007, Vol.46, p.S268-S269

2007

Volltextzugriff (PDF)

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Gut, 2013-02, Vol.62 (2), p.290-298

2013

Volltextzugriff (PDF)

Is liver stiffness measurement different in patients with NASH or with viral hepatitis?

Digestive and liver disease, 2008, Vol.40 (10), p.A128-A128

2008

Volltextzugriff (PDF)

Zafirlukast-related hepatitis: report of a further case

Journal of hepatology, 2001-10, Vol.35 (4), p.539-541

2001

Volltextzugriff (PDF)

Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment

Diseases of the colon & rectum, 2000-05, Vol.43 (5), p.609-613

2000

Volltextzugriff (PDF)

Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis

Minerva medica, 2004-02, Vol.95 (1), p.65

2004

Volltextzugriff (PDF)

Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B

Journal of hepatology, 2005-02, Vol.42 (2), p.173-179

2005

Volltextzugriff (PDF)

Identification of HBV DNA sequences that are predictive of response to lamivudine therapy

Hepatology (Baltimore, Md.), 2004-01, Vol.39 (1), p.64-73

2004

Volltextzugriff (PDF)

Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine

Journal of hepatology, 2003, Vol.39, p.168-171

2003

Volltextzugriff (PDF)

Disappearance of diabetes mellitus after conversion from fk 506 to neoral in two liver transplanted patients

Transplantation proceedings, 1998-08, Vol.30 (5), p.1863-1864

1998

Volltextzugriff (PDF)

Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B (e-CHB) patients completely responders during 5 years of therapy

Journal of hepatology, 2004-09, Vol.41 (3), p.500-501

2004

Volltextzugriff (PDF)

480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two years

Journal of hepatology, 2006-04, Vol.44, p.S178-S179

2006

Volltextzugriff (PDF)

Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation

Hepatology (Baltimore, Md.), 1998-03, Vol.27 (3), p.873-876

1998

Volltextzugriff (PDF)

Identification of HBV-DNA markers that are predictive of response to lamivudine therapy in patients infected with HBV precore variants

Journal of hepatology, 2003-04, Vol.38, p.134-134

2003

Volltextzugriff (PDF)

Efficacy of lamivudine therapy in chronic delta hepatitis: A multicenter randomized controlled pilot study

Journal of hepatology, 2003-04, Vol.38, p.159-159

2003

Volltextzugriff (PDF)

Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

Journal of hepatology, 2002-04, Vol.36, p.37-37

2002

Volltextzugriff (PDF)

10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

Digestive and liver disease, 2003-02, Vol.35, p.A5-A5

2003

Volltextzugriff (PDF)

Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment

Italian journal of neurological sciences, 1999-02, Vol.20 (1), p.49-54

1999

Volltextzugriff (PDF)

3 P Prophylaxis of HBV recurrence after liver transplantation in HBsAg-carriers. HBIG and lamivudine theraphy vs HBIG monotheraphy

Digestive and liver disease, 2002-06, Vol.34, p.A58-A58

2002

Volltextzugriff (PDF)

Long term lamivudine monotherapy in chronic E-antigen negative hepatitis B: efficacy and breakthroughs

Journal of hepatology, 2001-04, Vol.34, p.134-134

2001

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(37)

Sprache

Englisch
(33)
Italienisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study

F-14 Hypophosphatemia in Caucasian HBV patients treated with tenofovir is influenced by previous adefovir treatement

Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen‐negative chronic hepatitis B

Treatment of chronic hepatitis B

Current pharmacotherapy for the treatment of chronic hepatitis B

[712] IS LIVER STIFFNESS MEASUREMENT DIFFERENT IN PATIENTS WITH NASH OR WITH VIRAL HEPATITIS?

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Is liver stiffness measurement different in patients with NASH or with viral hepatitis?

Zafirlukast-related hepatitis: report of a further case

Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment

Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis

Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B

Identification of HBV DNA sequences that are predictive of response to lamivudine therapy

Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine

Disappearance of diabetes mellitus after conversion from fk 506 to neoral in two liver transplanted patients

Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B (e-CHB) patients completely responders during 5 years of therapy

480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two years

Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation

Identification of HBV-DNA markers that are predictive of response to lamivudine therapy in patients infected with HBV precore variants

Efficacy of lamivudine therapy in chronic delta hepatitis: A multicenter randomized controlled pilot study

Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment

3 P Prophylaxis of HBV recurrence after liver transplantation in HBsAg-carriers. HBIG and lamivudine theraphy vs HBIG monotheraphy

Long term lamivudine monotherapy in chronic E-antigen negative hepatitis B: efficacy and breakthroughs

Suchergebnisse filtern